Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
China's Hengrui Halts Most Generic Development
The Move Comes After Prices Free Fall In China
Oct 11 2019
•
By
Brian Yang
HENGRUI REPORTEDLY HALTS MOST GENERICS DEVELOPMENT AFTER HUGE PRICE FALL • Source: Scrip
More from Strategy
More from Business